Neonatal And Prenatal Devices Market Analysis France - Size and Forecast 2024-2028

France Neonatal And Prenatal Devices Market Size 2024-2028 

The France neonatal and prenatal devices market size is forecast to increase by USD 498.9 million, at a CAGR of 4.5% between 2023 and 2028.

• The market is driven by the rising incidence of preterm births and growing awareness of fetal screening and monitoring procedures. The increasing prevalence of preterm births necessitates advanced medical devices for neonatal care, fueling market growth. Additionally, the importance of early detection and intervention in fetal development has led to a surge in demand for prenatal devices.  In the healthcare services sector, medical technologies, including medical devices and diagnostics, are experiencing increased demand. However, affordability issues pose a significant challenge to market expansion.
• Despite these obstacles, opportunities exist for companies to innovate and offer cost-effective solutions, ensuring accessibility to a larger consumer base. By focusing on technological advancements and addressing affordability concerns, market participants can capitalize on the growing demand for neonatal and prenatal devices in France.

What will be the size of the France Neonatal And Prenatal Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.  
 Request Free Sample

• The French neonatal and prenatal devices market encompasses a range of technologies designed to enhance fetal and newborn health. Fetal biophysical profile and fetal echocardiography enable real-time assessment of fetal well-being, while amniotic fluid analysis aids in detecting potential complications. Neonatal nutrition and feeding support ensure optimal growth, with a focus on premature infant care and managing conditions like bronchopulmonary dysplasia. Neonatal care protocols incorporate advanced monitoring systems for brain function, respiratory distress syndrome, and retinopathy of prematurity. Preventive measures such as intraventricular hemorrhage management, neonatal infection control, and hypothermia prevention are essential. Prenatal vitamins and gestational diabetes screening contribute to improved maternal health, ultimately benefiting the newborn.
• Parental support groups and antenatal education programs provide essential resources for expectant parents, fostering a better understanding of neonatal care and postnatal recovery. Newborn health assessments and neonatal dermatology help identify and address various conditions. Neonatal sepsis management and ultrasound image analysis are crucial for timely intervention and effective treatment. Overall, the French market for neonatal and prenatal devices is characterized by continuous innovation and a commitment to improving the health and well-being of newborns.

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• End-user
  • Hospitals
  • Diagnostics centers
  • Others
• Type
  • Prenatal and fetal equipment
  • Neonatal equipment
• Geography
  • Europe
    • France

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period.

Neonatal and prenatal care markets in France witness continuous growth due to the increasing demand for advanced medical devices and technologies to ensure the health and well-being of pregnant women and newborn babies. Hospitals, particularly those with specialized neonatal intensive care units (NICUs), are the primary end-users of these devices. Pulse oximetry sensors, ultrasound technology, incubator technology, and electronic fetal monitoring systems are essential tools for neonatal care. Prenatal care involves various diagnostic imaging techniques, such as prenatal diagnostic imaging and uterine activity monitoring, to assess fetal development and detect potential issues like intrauterine growth restriction and fetal distress.

Newborn screening tests, including hearing screening and genetic screening, are crucial for early identification and intervention of health conditions. Temperature regulation systems, apnea monitors, and phototherapy equipment are essential for neonatal respiratory support and jaundice treatment. Labor induction techniques and cervical ripening methods are used to facilitate safe deliveries. Neonatal resuscitation devices and continuous fetal monitoring systems are essential for managing complications during childbirth. Advanced technologies like non-invasive prenatal testing and doppler fetal monitoring provide valuable insights into fetal health and development. Fetal anomaly detection and preterm birth prediction tools help healthcare professionals take proactive measures to ensure the best possible outcomes for both mothers and newborns.

Antenatal corticosteroids and fetal monitoring systems are crucial for managing high-risk pregnancies and reducing the risk of complications. Postnatal depression screening is essential for ensuring the emotional well-being of new mothers. In conclusion, the neonatal and prenatal care markets in France are driven by the increasing demand for advanced medical devices and technologies to ensure the health and well-being of pregnant women and newborn babies. Hospitals, particularly those with specialized neonatal intensive care units, are the primary end-users of these devices. The market encompasses a range of products and technologies, including pulse oximetry sensors, neonatal hearing screening, intrauterine growth restriction management, ventilator management, ultrasound technology, incubator technology, newborn screening tests, electronic fetal monitoring, infant warming devices, antenatal corticosteroids, postnatal depression screening, temperature regulation systems, fetal monitoring systems, prenatal diagnostic imaging, uterine activity monitoring, fetal distress indicators, preterm birth prediction, doppler fetal monitoring, phototherapy equipment, fetal anomaly detection, continuous fetal monitoring, non-invasive prenatal testing, neonatal resuscitation devices, prenatal genetic screening, cpap ventilation, bilirubin measurement, neonatal intensive care, cervical ripening methods, neonatal jaundice treatment, fetal well-being assessment, neonatal respiratory support, apnea monitors, and labor induction techniques.

Download Free Sample Report

The Hospitals segment was valued at  USD 983.60 million in 2018 and showed a gradual increase during the forecast period.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the France Neonatal And Prenatal Devices Market drivers leading to the rise in adoption of the Industry?

• The increasing prevalence of preterm births serves as the primary catalyst for market growth. 

• Preterm birth, or the delivery of a baby before 37 weeks of gestation, is a significant health concern worldwide. Factors contributing to this condition include short intervals between pregnancies, in-vitro fertilization, infections in amniotic fluid and lower genital tract, multiple miscarriages or abortions, multiple pregnancies, and chronic conditions like diabetes and high blood pressure during delivery. Preterm birth is categorized into three sub-groups based on the gestational age of the fetus: extremely preterm (less than 28 weeks), very preterm (28 to 32 weeks), and moderate-to-late preterm (32 to 37 weeks). Premature babies face high neonatal mortality in the first 28 days of life and potential short- or long-term morbidity, including cerebral palsy, sensory impairments, learning disabilities, breathing problems, developmental delays, and respiratory illnesses.
• Labor induction techniques are essential in managing preterm labor to improve neonatal outcomes. These methods include pharmacological and non-pharmacological interventions. Understanding the implications of preterm birth and the available interventions is crucial for healthcare professionals and policymakers to develop strategies for improving neonatal care and reducing associated complications.

What are the France Neonatal And Prenatal Devices Market trends shaping the Industry?

• The increasing importance of fetal screening and monitoring procedures is a notable trend in the current market. Professionals in the healthcare industry are increasingly focusing on advanced techniques to ensure the health and well-being of unborn children.

• Neonatal and prenatal devices play a crucial role in ensuring the health and wellbeing of newborns in France. With rising awareness of preterm and intrapartum-related neonatal mortality, there is an increasing focus on screening and monitoring procedures to minimize invasive testing and improve the chances of detecting chromosomal or genetic abnormalities in the fetus. Pulse oximetry sensors, neonatal hearing screening, ultrasound technology, and electronic fetal monitoring are some of the essential prenatal devices used for this purpose. Intrauterine growth restriction and ventilator management are other areas where these devices are making a significant impact. The French government and private organizations are promoting the advantages of fetal screening and monitoring through various initiatives.
• Genetic disorders, which account for a significant proportion of stillbirths, child mortality, morbidity, and Down syndrome, can be detected through these procedures. By addressing these conditions early, healthcare providers can improve pregnancy outcomes and reduce the risk of complications for both the mother and the baby. The demand for advanced prenatal devices is expected to grow as more women seek to ensure the health and wellbeing of their unborn children.

How does France Neonatal And Prenatal Devices Market face challenges during its growth?

• The affordability issue represents a significant challenge to the industry's growth trajectory. 

• Neonatal and prenatal devices play a crucial role in ensuring the health and well-being of infants and expectant mothers. However, affordability remains a significant challenge in the market. The high cost of neonatal devices, including infant warming devices, temperature regulation systems, and fetal monitoring systems, poses a barrier to access for many families. In healthcare centers, the use of these devices contributes to the high cost of pregnancy and delivery care, with NICU care per patient per day exceeding USD 125 in France. This financial burden is particularly challenging for middle-class families. Consequently, the affordability issues surrounding neonatal devices are anticipated to negatively influence the market during the forecast period.
• Additionally, prenatal devices such as antenatal corticosteroids, uterine activity monitoring, fetal distress indicators, and prenatal diagnostic imaging are essential for the health of both the mother and the baby. However, the high cost of these devices can limit their availability, particularly in primary healthcare centers. The affordability concerns extend to postnatal depression screening, which is essential for the mental health of new mothers. Addressing these affordability challenges will be critical for the growth and accessibility of neonatal and prenatal devices in France.

Exclusive France Neonatal And Prenatal Devices Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Atom Medical Corp.
• Baxter International Inc.
• Becton Dickinson and Co.
• Cardinal Health Inc.
• Dragerwerk AG and Co. KGaA
• Fisher and Paykel Healthcare Corp. Ltd.
• FUJIFILM Corp.
• General Electric Co.
• Getinge AB
• Inspiration Healthcare Group Plc.
• Koninklijke Philips N.V.
• Masimo Corp.
• Medtronic Plc
• Natus Medical Inc.
• Neoventa Medical AB
• Nihon Kohden Corp.
• OSI Systems Inc.
• Smiths Group Plc
• Utah Medical Products Inc.
• Vyaire Medical Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Neonatal And Prenatal Devices Market In France

• In January 2024, Medtronic, a global healthcare solutions company, announced the launch of the Harmony Neonatal Ventilator in France. This advanced ventilator is designed to improve oxygenation and ventilation for newborns and reduce the risk of complications (Medtronic Press Release, 2024).
• In March 2024, Philips and the Assistance Publique-Hôpitaux de Paris (AP-HP) signed a strategic partnership agreement to implement Philips' prenatal monitoring solutions in several AP-HP hospitals. This collaboration aims to enhance the quality of prenatal care and improve patient outcomes (Philips Press Release, 2024).
• In May 2025, Edwards Lifesciences, a leading provider of critical care monitoring and diagnostic solutions, completed the acquisition of Valedion, a French company specializing in non-invasive fetal and maternal monitoring. The acquisition is expected to expand Edwards' portfolio in the prenatal devices market and strengthen its presence in Europe (Edwards Lifesciences Press Release, 2025).
• In May 2025, the French Ministry of Solidarity and Health announced the launch of a new national program, "Investments for the Future," which includes a €200 million allocation for the development and implementation of innovative medical devices, including neonatal and prenatal devices (French Ministry of Solidarity and Health Press Release, 2025).

Research Analyst Overview

The market continues to evolve, driven by advancements in technology and growing demand for improved maternal and infant health outcomes. Infant warming devices, temperature regulation systems, and fetal monitoring systems are integral components of neonatal care, ensuring newborns receive optimal care during their critical first moments. Antenatal corticosteroids and postnatal depression screening are essential prenatal interventions, addressing complications that can impact both mother and child. Prenatal diagnostic imaging, such as ultrasound technology and fetal anomaly detection, provide valuable insights into fetal development, enabling early intervention and better outcomes. Uterine activity monitoring and fetal distress indicators are crucial tools for assessing fetal well-being and facilitating timely interventions.

The market is further enriched by the introduction of innovative technologies like continuous fetal monitoring, non-invasive prenatal testing, and neonatal resuscitation devices. These advancements contribute to the ongoing improvement of neonatal intensive care, addressing the complex needs of premature infants and those with respiratory distress. Moreover, preterm birth prediction, doppler fetal monitoring, and cervical ripening methods are essential components of obstetrical care, ensuring the best possible outcomes for both mother and child. The market's continuous dynamism is further underscored by the development of phototherapy equipment for neonatal jaundice treatment and neonatal respiratory support systems like CPAP ventilation and apnea monitors.

The integration of these devices and technologies into healthcare systems and practices underscores the importance of ongoing innovation and adaptation in the neonatal and prenatal devices market. This evolving landscape ensures that healthcare providers in France and beyond can deliver the highest standard of care to mothers and newborns, ultimately contributing to better health outcomes and improved patient experiences.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Neonatal And Prenatal Devices Market in France insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across France
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements Get in touch